Human herpes virus 8 infection in kidney transplant patients in Belgium

Nephrology Dialysis Transplantation

Volumn 15, Issue 9, 2000, Pages 1443-1445

  Sheldon, Julie ^a   Henry, Stéphanie ^b   Mourad, Michel ^b   Bodéus, Monique ^b   Squifflet, Jean Paul ^b   Schulz, Thomas F ^a   Goubau, Patrick ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Belgium; Human herpes virus type 8; Kaposi sarcoma; Kidney graft

Indexed keywords

VIRUS ANTIBODY; VIRUS ANTIGEN;

ARTICLE; BELGIUM; BLOOD TRANSFUSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; HUMAN TISSUE; IMMUNOFLUORESCENCE; INFECTION RATE; INFECTION RISK; KAPOSI SARCOMA; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OPEN READING FRAME; ORGAN DONOR; PREVALENCE; PRIORITY JOURNAL; RECIPIENT; SCREENING; SEROCONVERSION; SERUM; WESTERN BLOTTING;

EID: 0033828596     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.9.1443     Document Type: Article

References (20)

1. Identification of herpes virus-like DNA sequences in AIDS-associated Kaposi's sarcoma
2. Human herpes virus-like nucleic acid in various forms of Kaposi's sarcoma
3. Herpes virus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma
4. Kaposi's sarcoma associated herpes virus in HIV-negative Kaposi's sarcoma
5. The seroepidemiology of human herpes virus 8 (Kaposi's sarcoma-associated herpes virus) distribution of infection in KS risk groups and evidence for sexual transmission
6. KSVH antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
7. Prevalence of Kaposi's sarcoma-associated herpes virus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
8. Prevalence and transmission of Kaposi's sarcoma-associated herpes virus (human herpesvirus 8) in Ugandan children and adolescents
9. Kaposi's sarcoma among persons with AIDS: A sexually transmitted infection?
10. Seroprevalence of Kaposi's sarcoma herpes virus (KSHV/HHV8) in different regions of Italy
11. Human herpes virus 8 seroprevalence in blood donors and patients with lymphoma from different regions of Italy
12. Kaposi's sarcoma in renal transplant recipients
13. Serologic association of human herpes virus 8 with posttransplant Kaposi's sarcoma in Saudi Arabia
14. Posttransplantation Kaposi's sarcoma appearing simultaneously in same cadaver donor renal transplant recipients
15. Transmission of human herpes virus 8 infection from renal-transplant donors to recipients
16. Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients
17. Human herpes virus 8 (HHV8) and other risk factors for Kaposi's sarcoma in kidney transplant recipients
18. The 222-234 kd latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpes virus (human herpes virus 8) is encoded by orf 73 and is a component of the latency-associated nuclear antigen
19. Seroconversion for Kaposi's sarcoma-associated herpes virus is highly predictive of KS development in HIV-l infected individuals
20. Interassay correlation of human herpes virus 8 serologic tests